Quarterly Result7 Aug 2025, 06:42 pm
IOL Chemicals & Pharmaceuticals Reports Robust Q1 FY26 Performance
AI Summary
IOL Chemicals & Pharmaceuticals Ltd., one of the leading manufacturers of Bulk Drugs & Specialty Chemicals, announced its Financial Results for the quarter ended on 30th June 2025. The company reported a 9.8% Y-o-Y growth in Revenue from Operations, 19.5% growth in EBITDA, and a 14.4% growth in Profit After Tax. The chemicals segment saw a successful REACH registration of Acetic Anhydride under EU norms, opening up new growth avenues in Europe. The company is focusing on scaling high-value APIs, deepening its export footprint, and driving operational excellence.
Key Highlights
- Revenue from Operations grew by 9.8% Y-o-Y to 551.7 Cr
- EBITDA increased by 19.5% Y-o-Y to 69.5 Cr
- Profit After Tax saw a growth of 14.4% Y-o-Y to 34.0 Cr
- Successfully obtained REACH registration for Acetic Anhydride under EU regulations
- Focus on scaling high-value APIs and deepening export footprint